鄰近類別 報告 [0/1] 專利 [0/11] 期刊論文 [193/194] 類別統計 近3年內發表的文件:0(0.00%) 含全文筆數:41(85.42%) 文件下載次數統計 下載大於0次:41(100.00%) 下載大於100次:41(100.00%) 檔案下載總次數:24093(16.36%) 最後更新時間: 2024-12-04 18:39 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Cathepsin S inhibition alleviates o... Phase I study of biweekly liposome ... The clinical implication of O6 meth... O6BG modulates the repair activity ... Phase I dose-escalation study of so... Targeting cathepsin S induces tumor... MPT0B098, a novel microtubule inhib... Down-regulation of survivin enhance... Activation of NRF2/ABCC1 axis confe... DNA polymerase eta and a novel anti...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-48 / 48. (共1頁) 1  每頁顯示[10|25|50]項目

日期	題名	關聯
2019-07	Cathepsin S inhibition alleviates oxaliplatin-induced peripheral neuropathy through regulation of Ca2+homeostasis	Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 2942.
2018-12	The clinical implication of O6 methylguanine DNA methyltransferase in rectal cancers	Cancer Science. 2018 Dec;109(Suppl. 2):1369.
2018-01	O6BG modulates the repair activity of homologous recombination and its clinical application	Cancer Science. 2018 Jan;109(Suppl. 1):379.
2016-02	Phase I dose-escalation study of sorafenib plus S-1 in refractory solid tumors	Journal of Clinical Oncology. 2016 Feb;34(4, Suppl.):Meeting Abstract 745.
2015-08	MPT0B292 enhances acetylation of alpha-tubulin through up-regulation of acetyltransferase gene, MEC-17 and exhibits potent anti-tumor, anti-angiogenesis and anti-metastatic effects in vitro and in vivo	Cancer Research. 2015 Aug;75(Suppl. 15):Abstract number 4379.
2015-05	Enhanced antitumor activity of rapamycin and genipin, a UCP-2 inhibitor, in lung cancer	Journal of Clinical Oncology. 2015 May;33(15, Suppl.):e13595.
2015-04	The role of miR-450a in oral squamous cell carcinoma carcinogenesis	FASEB Journal. 2015 Apr;29(1, Suppl.):Abstract number 711.22.
2014-11	CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors	European Journal of Cancer. 2014 Nov;50(Suppl. 6):19-20.
2014-10	Genetic polymorphisms of genes on the retinoic acid pathway and risk of head and neck cancer	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 4145.
2014-10	Copper-chelator exerts synergistic interaction with platinum drugs through modulating copper transporters in oxaliplatin-resistant human gastric cancer cell	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 3753.
2014-10	Identification of oral carcinoma miRNA signature and control OSCC tumorigenesis through Wnt/beta-catenin signaling	Cancer Research. 2014 Oct;74(19 Suppl.):Abstract No. 1487.
2014-06	Reconstruction of exposed cohort and cumulative dose of radio-contaminated building residents for epidemiological study - Updated information	Occupational and Environmental Medicine. 2014 Jun;71(Suppl. 1):A69.
2014-05	High expression of Hsp90-beta and GRP 94 association with poor survival in resected non-small cell lung cancer patients	Journal of Clinical Oncology. 2014 May;32(15, Suppl.):e13522.
2013-06	Oral hygiene and risk of head and neck cancer	American Journal of Epidemiology. 2013 Jun;177(Suppl. 11):S58.
2013-04	Functional implication of TGFBR3 dysregulation and its clinical application in oral cancer	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 3987.
2013-04	Generation and characterization of highly selective cathepsin S inhibitors with potentials against pancreatic cancer	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 5562.
2013-04	EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 2390.
2013-04	Autophagy induced by cathepsin S inhibition causes early ROS production for oxidative DNA damage and subsequent cell death	Cancer Research. 2013 Apr;73(8 Suppl. 1):Abstract number 1661.
2012-11	Overexpression of Discoidin Domain Receptor 1 (DDR1) in oral squamous cell carcinoma	European Journal of Cancer. 2012 Nov;48(Suppl. 6):167.
2012-11	Blockage of Nrf2/AKR1C axis enhanced therapeutic efficacy of oxaliplatin in oxaliplatin resistant gastric cancer cells	European Journal of Cancer. 2012 Nov;48(Suppl. 6):48.
2012-11	MicroRNA-99a, a tumor suppressor in oral squamous cell carcinoma regulates insulin-like growth factors I receptor in a double-negative feedback loop	European Journal of Cancer. 2012 Nov;48(Suppl. 6):120.
2012-04	DNA polymerase eta and a novel anticancer selenophene compound	Cancer Research. 2012 Apr;72:Abstract number 3813.
2012-02	Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy	Journal of Clinical Oncology. 2012 Feb;30(4):613.
2011-09-23	BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo	European Journal of Cancer. 2011 Sep 23;47:S127.
2011-09-23	A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou	European Journal of Cancer. 2011 Sep 23;47:S547-S548.
2011-09	DNA repair enzyme, O6-methylguanine DNa methyltransferase, modulates therapeutic efficacy of platinum drugs with radiation and its clinical significance	European Journal of Cancer. 2011 Sep;47:S132.
2011-07	MicroRNA signature and aberrant methylation in human oral squamous cell carcinomas	Oral Oncology. 2011 Jul;47(Suppl. 1):S92.
2011-05	Pharmacokinetic study with novel anticanacer agents, MPTOB124 and MPTOB214	Drug Metabolism Reviews. 2011 May;43(Suppl. 1):73.
2011-04	Activation of Akt/FoxO axis confers resistance to cisplatin in human nasopharyngeal carcinomas	Cancer Research. 2011 Apr;71:Abstract number 1701.
2011-04	Activation of NRF2/ABCC1 axis confers resistance to topoisomerase II poisons in human oral malignancies	Cancer Research. 2011 Apr;71:Abstract number 1528.
2011-04	MPT0B098, a novel microtubule inhibitor, displays potent anti-angiogenic activity via destabilizing hypoxia-inducible factor-1alpha mRNA	Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 4461.
2011-04	Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway	Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 2864.
2010-10	Combined modalities of resistance in a cisplatin-driven human betel-associated oral squamous cell carcinoma	Annals of Oncology. 2010 Oct;21(Suppl. 8):52.
2010-06	Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma	Annals of Oncology. 2010 Jun;21(Suppl. 6):27.
2009-09	Synergistic augmentation of arsenic trioxide-induced cytotoxicity by BCNU through reactive oxygen species-related autophagic pathway in human solid tumors	EJC Supplements. 2009 Sep;7(3):16.
2009-05-20	Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)	Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 4587.
2009-05	Down-regulation of survivin enhances sensitivity to BPROL075 in human cancer cells via caspase-independent mechanisms	Cancer Research. 2009 May;69:Abstract number 5542.
2007-07	A novel oral indoline-sulfonamide derivative, J30, exhibits potent activity against human cancer cells both in in vitro and in vivo through disruption of microtubule	Drugs of the Future. 2007 Jul;32(Suppl. A):35-36.
2006-11	Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity	EJC Supplements. 2006 Nov;4(12):59.
2006-11	D-501036, a novel selenophene-base triheterocycle derivative exhibits potent in vitro and in vivo anti-tumoral activity, which involves DNA-damage and ATM activation	EJC Supplements. 2006 Nov;4(12):92.
2006-11	Tamoxifen induces degradation of the o6-methylguanine DNA methyltransferase protein via the ubiquitin-dependent proteosome pathway in human cancer cells	EJC Supplements. 2006 Nov;4(12):155.
2006-02	DNA repair enzyme, O-6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors	Journal of Pharmacology and Experimental Therapeutics. 2006 Feb;316(2):946-954.
2006-01	Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma	Head and Neck. 2006 Jan;28(1):74-80.
2005-12	Induction of cell death by a novel selenophene derivative, D-501036, in human cancer cell lines	Clinical Cancer Research. 2005 Dec;11(24):9101S.
2004-09	Drug design of BPR0L075 as an anticancer agent	World Conference on Magic Bullets - Celebrating Paul Ehrlich's 150th Birthday. 2004 Sep 9-11:Abstract # 203.
2004-08-02	Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer	British Journal of Cancer. 2004 Aug;91(3):453-458.
2004-07	Drug design for BPR0L075 as an anticancer agent	Medicine in the 21st Century Tri-Conference & Bio-Forum 2004 Shanghai International Convention Center. 2004 Jul.
2002	Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma	International Journal of Cancer. 2002;Suppl. 13:336-337.

顯示項目1-48 / 48. (共1頁) 1  每頁顯示[10|25|50]項目